New Guidance on Resmetirom and Semaglutide for MASH

(MedPage Today) — At the annual meeting of the American Association for the Study of Liver Diseases (AASLD), a session highlighted new guidelines for the use of resmetirom (Rezdiffra) and semaglutide (Ozempic, Wegovy) for steatohepatitis associated with metabolic dysfunction…